Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital…
Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that the US FDA has granted priority review…
Read More...
Read More...